We are live on
!
Find out more
BM
Bridger Management Portfolio holdings
AUM
$128M
1-Year Est. Return
9.54%
This Fund
S&P 500
This Quarter
Est. Return
+17.78%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$261M
AUM Growth
-$12M
(-4.4%)
Cap. Flow
-$41.8M
Cap. Flow
% of AUM
-16.04%
Top 10 Holdings %
Top 10 Hldgs %
69%
Holding
42
New
10
Increased
3
Reduced
4
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$10.6M |
| 2 |
Xenon Pharmaceuticals
XENE
|
+$5.19M |
| 3 |
AtriCure
ATRC
|
+$3.24M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$3.22M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
+$2.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Melco Resorts & Entertainment
MLCO
|
+$14.3M |
| 2 |
Biogen
BIIB
|
+$8.81M |
| 3 |
Alcon
ALC
|
+$7.8M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
+$7.41M |
| 5 |
Charter Communications
CHTR
|
+$7.18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.11% |
| 2 | Technology | 24.55% |
| 3 | Consumer Discretionary | 17.42% |
| 4 | Communication Services | 8.67% |
| 5 | Financials | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Uber
UBER
$143B
| $27.4M | 10.51% |
445,357
-64,000
| -13% | -$3.35M |
|
2
GoDaddy
GDDY
$10.5B
| $25.1M | 9.62% |
236,244
| – | – |
|
3
Caesars Entertainment
CZR
$6.06B
| $20.1M | 7.69% |
427,925
| – | – |
|
4
Vertex Pharmaceuticals
VRTX
$121B
| $19.5M | 7.49% |
48,000
+5,600
| +13% | +$2.07M |
|
5
Morgan Stanley
MS
$332B
| $17M | 6.5% |
181,914
| – | – |
|
6
Eli Lilly
LLY
$1.02T
| $16.4M | 6.27% |
28,076
| – | – |
|
7
Teva Pharmaceuticals
TEVA
$40.9B
| $15.7M | 6% |
1,500,000
| – | – |
|
8
Bath & Body Works
BBWI
$4.05B
| $14.3M | 5.5% |
332,327
-64,000
| -16% | -$2.16M |
|
9
US Foods
USFD
$22.1B
| $14.2M | 5.44% |
312,331
| – | – |
|
|
EDR
10
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $10.4M | 3.97% |
436,860
| – | – |
|
|
11
Charter Communications
CHTR
$17.4B
| $10.3M | 3.95% |
26,513
-17,600
| -40% | -$7.18M |
|
|
12
Pfizer
PFE
$143B
| $10.1M | 3.87% |
+350,500
| New | +$10.6M |
|
|
DCBO
13
Docebo
DCBO
$520M
| $9.33M | 3.58% |
192,892
+36,000
| +23% | +$1.6M |
|
14
Crown Holdings
CCK
$12.8B
| $9.12M | 3.5% |
99,000
| – | – |
|
|
15
Xenon Pharmaceuticals
XENE
$6.1B
| $6.76M | 2.59% |
+146,800
| New | +$5.19M |
|
16
Quanterix
QTRX
$164M
| $4.23M | 1.62% |
154,900
| – | – |
|
|
SWTX
17
DELISTED
SpringWorks Therapeutics
SWTX
| $3.69M | 1.42% |
+101,126
| New | +$2.64M |
|
|
18
Acadia Pharmaceuticals
ACAD
$4.38B
| $3.67M | 1.41% |
+117,341
| New | +$2.8M |
|
|
19
Alnylam Pharmaceuticals
ALNY
$27.1B
| $3.62M | 1.39% |
+18,922
| New | +$3.22M |
|
|
WRAC
20
DELISTED
Williams Rowland Acquisition Corp.
WRAC
| $3.11M | 1.19% |
297,000
| – | – |
|
|
21
AtriCure
ATRC
$1.93B
| $3.11M | 1.19% |
+87,100
| New | +$3.24M |
|
|
CPRX
22
DELISTED
Catalyst Pharmaceutical
CPRX
| $3.1M | 1.19% |
+184,527
| New | +$2.52M |
|
23
uniQure
QURE
$3.02B
| $2.45M | 0.94% |
362,349
+350,340
| +2,917% | +$2.32M |
|
24
Alphabet (Google) Class A
GOOGL
$4.33T
| $1.94M | 0.74% |
13,900
| – | – |
|
|
25
Melco Resorts & Entertainment
MLCO
$2.26B
| $1.9M | 0.73% |
214,763
-1,750,359
| -89% | -$14.3M |
|
Similar funds
SHFC
IUC
PC
SIM
PIA
S
CF
BC
Bridger Management's Q4 2023 Portfolio in Review
As of Q4 2023, Bridger Management held 42 positions worth $261M, down 4.4% from $273M the previous quarter. Its ten largest holdings account for 69% of the portfolio.
Bridger Management withdrew a net $41.8M in Q4 2023, closing 12 positions and reducing 4 holdings. Its most notable exit was Biogen, an estimated $8.81M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Bridger Management opened a new position in Pfizer worth $10.1M.
- Bridger Management's largest Q4 2023 buy was Pfizer: 350,500 shares worth $10.1M.
- Bridger Management added most to uniQure in Q4 2023, an estimated $2.32M increase.
- Bridger Management's biggest Q4 2023 reduction was Melco Resorts & Entertainment, cutting an estimated $14.3M.
- Bridger Management fully exited Biogen in Q4 2023, selling an estimated $8.81M.
- Bridger Management's ten largest holdings make up 69% of its $261M portfolio in Q4 2023.
- Bridger Management opened 10 new positions and closed 12 in Q4 2023.
- Bridger Management's portfolio value fell 4.4% quarter-over-quarter to $261M.
Based on Bridger Management's 13F filing for Q4 2023, filed 14 Feb 2024.